SKI Market

A+| A| A-|

Indian Indices

Sensex

77,303.63 639.42
( 0.83%)

Global Indices

Nasdaq

49,198.35 -53.37
(-0.11%)

Dow Jones

7,195.79 9.71
(0.14%)

Hang Seng

60,447.00 730.82
(1.22%)

Nikkei 225

10,331.11 -47.97
(-0.46%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Aarti Drugs consolidated net profit rises 29.33% in the September 2025 quarter

Nov 07,2025

Net profit of Aarti Drugs rose 29.33% to Rs 45.28 crore in the quarter ended September 2025 as against Rs 35.01 crore during the previous quarter ended September 2024. Sales rose 9.10% to Rs 652.79 crore in the quarter ended September 2025 as against Rs 598.33 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	652.79	598.33	9
OPM %	12.91	11.21	-
PBDT	76.67	59.60	29
PBT	60.41	45.88	32
NP	45.28	35.01	29

77,303.63 639.42 ( 0.83%)

49,198.35 -53.37 (-0.11%)

7,195.79 9.71 (0.14%)

60,447.00 730.82 (1.22%)

10,331.11 -47.97 (-0.46%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)